Pharma Mar Statistics

Total Valuation

Pharma Mar has a market cap or net worth of GBP 1.35 billion. The enterprise value is 1.27 billion.

Market Cap	1.35B
Enterprise Value	1.27B

Important Dates

The next estimated earnings date is Friday, February 28, 2025.

Earnings Date	Feb 28, 2025
Ex-Dividend Date	Jun 12, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	12.57M

Valuation Ratios

The trailing PE ratio is 2,605.39.

PE Ratio	2,605.39
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	8.96
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	2,458.51
EV / Sales	9.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-86.56

Financial Position

The company has a current ratio of 2.66, with a Debt / Equity ratio of 0.29.

Current Ratio	2.66
Quick Ratio	1.99
Debt / Equity	0.29
Debt / EBITDA	34.15
Debt / FCF	-3.03
Interest Coverage	-1.47

Financial Efficiency

Return on equity (ROE) is 0.32% and return on invested capital (ROIC) is -0.91%.

Return on Equity (ROE)	0.32%
Return on Assets (ROA)	-0.65%
Return on Invested Capital (ROIC)	-0.91%
Return on Capital Employed (ROCE)	-1.45%
Revenue Per Employee	273,026
Profits Per Employee	1,017
Employee Count	509
Asset Turnover	0.49
Inventory Turnover	0.23

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +127.49% in the last 52 weeks. The beta is 0.04, so Pharma Mar's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	+127.49%
50-Day Moving Average	78.95
200-Day Moving Average	53.07
Relative Strength Index (RSI)	73.32
Average Volume (20 Days)	567

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Pharma Mar had revenue of GBP 138.97 million and earned 517,593 in profits. Earnings per share was 0.03.

Revenue	138.97M
Gross Profit	131.21M
Operating Income	-2.95M
Pretax Income	-3.36M
Net Income	517,593
EBITDA	-396,933
EBIT	-2.95M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 120.16 million in cash and 44.50 million in debt, giving a net cash position of 75.66 million.

Cash & Cash Equivalents	120.16M
Total Debt	44.50M
Net Cash	75.66M
Net Cash Per Share	n/a
Equity (Book Value)	151.59M
Book Value Per Share	8.64
Working Capital	123.64M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.37 million and capital expenditures -16.07 million, giving a free cash flow of -14.70 million.

Operating Cash Flow	1.37M
Capital Expenditures	-16.07M
Free Cash Flow	-14.70M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 94.42%, with operating and profit margins of -2.12% and 0.37%.

Gross Margin	94.42%
Operating Margin	-2.12%
Pretax Margin	-2.41%
Profit Margin	0.37%
EBITDA Margin	-0.29%
EBIT Margin	-2.12%
FCF Margin	n/a

Dividends & Yields

Pharma Mar does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	21.36%
Years of Dividend Growth	5
Payout Ratio	1,836.01%
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	0.04%
FCF Yield	-1.09%

Dividend Details

Stock Splits

The last stock split was on July 22, 2020. It was a reverse split with a ratio of 0.0833333333.

Last Split Date	Jul 22, 2020
Split Type	Reverse
Split Ratio	0.0833333333

Scores

Pharma Mar has an Altman Z-Score of 4.17.

Altman Z-Score	4.17
Piotroski F-Score	n/a